Cargando…

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliore, A, Gigliucci, G, Petrella, RJ, Bannuru, RR, Chevalier, X, Maheu, E, Raman, R, Herrero-Beaumont, G, Isailovic, N, Matucci Cerinc, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935020/
https://www.ncbi.nlm.nih.gov/pubmed/31920321
http://dx.doi.org/10.2147/TCRM.S221562
_version_ 1783483501265289216
author Migliore, A
Gigliucci, G
Petrella, RJ
Bannuru, RR
Chevalier, X
Maheu, E
Raman, R
Herrero-Beaumont, G
Isailovic, N
Matucci Cerinc, M
author_facet Migliore, A
Gigliucci, G
Petrella, RJ
Bannuru, RR
Chevalier, X
Maheu, E
Raman, R
Herrero-Beaumont, G
Isailovic, N
Matucci Cerinc, M
author_sort Migliore, A
collection PubMed
description Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a “treat to target strategy” for KOA.
format Online
Article
Text
id pubmed-6935020
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69350202020-01-09 It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis Migliore, A Gigliucci, G Petrella, RJ Bannuru, RR Chevalier, X Maheu, E Raman, R Herrero-Beaumont, G Isailovic, N Matucci Cerinc, M Ther Clin Risk Manag Expert Opinion Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a “treat to target strategy” for KOA. Dove 2019-12-23 /pmc/articles/PMC6935020/ /pubmed/31920321 http://dx.doi.org/10.2147/TCRM.S221562 Text en © 2019 Migliore et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Expert Opinion
Migliore, A
Gigliucci, G
Petrella, RJ
Bannuru, RR
Chevalier, X
Maheu, E
Raman, R
Herrero-Beaumont, G
Isailovic, N
Matucci Cerinc, M
It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title_full It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title_fullStr It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title_full_unstemmed It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title_short It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
title_sort it is the time to think about a treat-to-target strategy for knee osteoarthritis
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935020/
https://www.ncbi.nlm.nih.gov/pubmed/31920321
http://dx.doi.org/10.2147/TCRM.S221562
work_keys_str_mv AT migliorea itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT gigliuccig itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT petrellarj itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT bannururr itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT chevalierx itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT maheue itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT ramanr itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT herrerobeaumontg itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT isailovicn itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis
AT matuccicerincm itisthetimetothinkaboutatreattotargetstrategyforkneeosteoarthritis